Literature DB >> 2851499

Synthesis of the major inner capsid protein VP6 of the human rotavirus Wa in Escherichia coli.

H Ernst1, D Stroup.   

Abstract

The gene for the major inner capsid protein VP6 of human rotavirus strain Wa has been cloned and placed into a bacterial expression vector under the control of the inducible hybrid trp-lac (tac) promoter. Recombinant VP6 was produced at low levels in a cell-free Escherichia coli transcription-translation system programmed with this expression plasmid. The yield of VP6 synthesized in the extract could be increased several-fold by introduction of point mutations upstream and downstream from the start codon. Upon induction with IPTG, E. coli JM105 cells harboring the mutated expression plasmid produced VP6 as shown by immunoblotting of proteins from bacterial lysates with anti-Wa antiserum. Recombinant VP6 appeared to inhibit the growth of E. coli and did not accumulate in the cells to high levels. Conformational analysis with a monoclonal antibody suggested that bacterially produced VP6 adopted an oligomeric structure characteristic for native VP6.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2851499     DOI: 10.1016/0378-1119(88)90037-6

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  3 in total

1.  Nucleotide sequence of genomic segment 2 of the human rotavirus Wa.

Authors:  H Ernst; J A Duhl
Journal:  Nucleic Acids Res       Date:  1989-06-12       Impact factor: 16.971

2.  Mapping of antigenic sites on the major inner capsid protein of avian rotavirus using an Escherichia coli expression system.

Authors:  H Ito; N Minamoto; H Goto; T R Luo; M Sugiyama; T Kinjo
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

3.  Peptide-Recombinant VP6 Protein Based Enzyme Immunoassay for the Detection of Group A Rotaviruses in Multiple Host Species.

Authors:  Naveen Kumar; Yashpal Singh Malik; Satish Kumar; Kuldeep Sharma; Subhankar Sircar; Sharad Saurabh; Baldev R Gulati; Neeraj Singh; Arvind Kumar Singh; Vinay G Joshi; Krisztian Banyai; Kuldeep Dhama
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.